A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Early detection of breast cancer rectifies inequality of breast cancer outcomes




TekijätTabar L, Chen THH, Yen AMF, Dean PB, Smith RA, Jonsson H, Tornberg S, Chen SLS, Chiu SYH, Fann JCY, Ku MMS, Wu WYY, Hsu CY, Chen YC, Svane G, Azavedo E, Grundstrom H, Sunden P, Leifland K, Frodis E, Ramos J, Epstei B, Akerlund A, Sundbom A, Bordas P, Wallin H, Starck L, Bjorkgren A, Carlson S, Fredriksson I, Ahlgren J, Ohman D, Holmberg L, Duffy SW, Duffy SW

KustantajaSAGE PUBLICATIONS LTD

Julkaisuvuosi2020

JournalJournal of Medical Screening

Tietokannassa oleva lehden nimiJOURNAL OF MEDICAL SCREENING

Lehden akronyymiJ MED SCREEN

Artikkelin numeroARTN 0969141320921210

Sivujen määrä5

ISSN0969-1413

eISSN1475-5793

DOIhttps://doi.org/10.1177/0969141320921210

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/50360192


Tiivistelmä
Objectives To explain apparent differences among mammography screening services in Sweden using individual data on participation in screening and with breast cancer-specific survival as an outcome.Methods We analysed breast cancer survival data from the Swedish Cancer Register on breast cancer cases from nine Swedish counties diagnosed in women eligible for screening. Data were available on 38,278 breast cancers diagnosed and 4312 breast cancer deaths. Survival to death from breast cancer was estimated using the Kaplan-Meier estimate, for all cases in each county, and separately for cases of women participating and not participating in their last invitation to screening. Formal statistical comparisons of survival were made using proportional hazards regression.Results All counties showed a reduction in the hazard of breast cancer death with participation in screening, but the reductions for individual counties varied substantially, ranging from 51% (95% confidence interval 46-55%) to 81% (95% confidence interval 74-85%). Survival rates in nonparticipating women ranged from 53% (95% confidence interval 40-65%) to 74% (95% confidence interval 72-77%), while the corresponding survival in women participating in screening varied from 80% (95% confidence interval 77-84%) to 86% (95% confidence interval 83-88%), a considerably narrower range.Conclusions Differences among counties in the effect of screening on breast cancer outcomes were mainly due to variation in survival in women not participating in screening. Screening conferred similarly high survival rates in all counties. This indicates that the performance of screening services was similar across counties and that detection and treatment of breast cancer in early-stage reduces inequalities in breast cancer outcome.

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 22:32